Drugmaker Seeks FDA Approval Over-the-counter Birth Control
Approval could come next year and would only apply to HRA’s pill
For the first time, a pharmaceutical company has asked for permission to sell a birth control pill over the counter in the United States.
HRA Pharma’s application on Monday sets up a high-stakes decision for health regulators amid legal and political battles over women’s reproductive health. The company says the timing was unrelated to the Supreme Court’s recent decision overturning Roe v. Wade.
Hormone-based pills have long been the most common form of birth control in the U.S., used by millions of women since the 1960s. They have always required a prescription, generally so health professionals can screen for conditions that raise the risk of rare, but dangerous, blood clots.
Please select this link to read the complete article from The Associated Press.